A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)
Clinical trial NCT01582308 · COMPLETED
Trial details
- NCT number
- NCT01582308
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-21
- Primary completion
- 2012-12-04
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.